| SPEC | specificity |
|---|---|
| ABL | abetalipoproteinemia; acceptable blood loss; African Burkitt lymphoma; Albright-Butler-Lightwood [sy... |
| BW | bacteriological warfare; bed wetting; below waist; biological warfare; biological weapon; birth weig... |
| RBE | Relative Biological Effectiveness |
| ABC | absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a... |
| CPSF | Cleavage and polyadenylation specificity factor |
|---|---|
| SP | Specificity |
| SPEC | specificity |
| B.E.I. | Biological Exposure Index |
| BI | biological indicator |
| biological specificity | <biology, zoology> The specific, orderly patterns of development and metabolism which define and characterise an individual and its species. (21 Mar 1998) |
|---|
| analytical specificity | Freedom from interference by any element or compound other than the analyte. (05 Mar 2000) |
|---|---|
| antibody specificity | The property of antibodies which enables them to react with some antigenic determinants and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. (12 Dec 1998) |
| relative specificity | The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test). (05 Mar 2000) |
| sensitivity and specificity | Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person. (12 Dec 1998) |
| species specificity | Restriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species. (12 Dec 1998) |
| specificity | The ability of the immune response to interact with individual antigens. (09 Oct 1997) |
| specificity constant | Ratio of the maximum velocity (Vmax) or kcat to the true Km value for a specific substrate in an enzyme-catalyzed reaction. (05 Mar 2000) |
| substrate specificity | A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. (12 Dec 1998) |
| diagnostic specificity | The probability (P) that, given the absence of disease (D), a normal test result (T) excludes disease; i.e., P(T/D). (05 Mar 2000) |
| organ specificity | Restriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology. (12 Dec 1998) |
| biological | Pertaining to biology. (18 Nov 1997) |
| biological agent | <microbiology> A disease-causing microorganism or virus, or other toxic biological matter, which is used as a weapon during war. (21 Mar 1998) |
| biological assay | <technique> Once a pharmaceutical protein is isolated from the cells in which it was grown, researchers perform tests to measure the protein's biological activity. It must maintain a certain minimal level of biological activity to be used for animal or clinical testing or, later, for market. Researchers also test to confirm that the isolated protein is identical to the desired protein. (21 Mar 1998) |
| biological assessment | A specific process required as part of an environmental assessment. An evaluation of potential effects of a proposed project on proposed, endangered, threatened, and sensitive animal and plant species and their habitats. (05 Dec 1998) |
| biological availability | The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|